Clinical and Epidemiological Features of Acute Zika Virus Infections in León, Nicaragua.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
09 08 2021
Historique:
received: 09 10 2020
accepted: 25 04 2021
pubmed: 10 8 2021
medline: 19 2 2022
entrez: 9 8 2021
Statut: epublish

Résumé

The American Zika virus (ZIKV) epidemic has highlighted the need to gain a better understanding of this emerging virus. The goal of this study was to describe the clinical symptoms, laboratory findings, and risk factors for symptomatic ZIKV infection in an area with ongoing transmission of other arboviral infections. We recruited patients at least 2 years of age seeking care at public health centers in León, Nicaragua, between January 2016 and August 2017, for fever, maculopapular rash, and/or nonsuppurative conjunctivitis with a duration of less than 1 week. A laboratory diagnosis of ZIKV was established using a combination of molecular and serological tests. Clinical and laboratory findings and potential risk factors were compared between participants with and without acute ZIKV infection. Fifty-eight (26%) of the 225 participants included in the analysis were found to have acute ZIKV infection. Pregnancy and reports of previous arboviral infection were associated with a higher risk of ZIKV infection. Rash, conjunctivitis, sore throat, and lower absolute neutrophil counts were associated with acute ZIKV infection. The clinical characteristics and risk factors identified were consistent with those identified by previous studies; however, we found sore throat to be a feature of ZIKV infection. We also found that neutrophil counts were lower in ZIKV-infected subjects. These clinical symptoms and laboratory data may help clinicians suspect ZIKV infection during future outbreaks.

Identifiants

pubmed: 34370700
doi: 10.4269/ajtmh.20-1191
pii: tpmd201191
pmc: PMC8592149
doi:
pii:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

924-930

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010923
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI141744
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI129532
Pays : United States
Organisme : NIAID NIH HHS
ID : K23 AI113197
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008719
Pays : United States
Organisme : FIC NIH HHS
ID : R25 TW009340
Pays : United States

Auteurs

Natalie M Bowman (NM)

Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Filemón Bucardo (F)

Department of Microbiology and Parasitology, Universidad Nacional Autónoma de Nicaragua-León, Nicaragua.

Matthew H Collins (MH)

The Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Emory University School of Medicine, Decatur, Georgia.

Yaoska Reyes (Y)

Department of Microbiology and Parasitology, Universidad Nacional Autónoma de Nicaragua-León, Nicaragua.
Division of Molecular Medicine and Virology, Department of Clinical and Biomedical Sciences, Linköping University, Linköping, Sweden.

Edwing Centeno Cuadra (E)

Department of Microbiology and Parasitology, Universidad Nacional Autónoma de Nicaragua-León, Nicaragua.

Bryan Blette (B)

Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Premkumar Lakshmanane (P)

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Enrique Paulo Guerra (EP)

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Rebecca Rubinstein (R)

School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Guei-Jiun Alice Liou (GA)

College of Osteopathic Medicine, Kansas City University, Kansas City, Missouri.

Aravinda M de Silva (AM)

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Sylvia Becker-Dreps (S)

Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH